Sebastian Such

Mr. Sebastian Such

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
SSSebastian Such
Sebastian Such
CPCzesław Puchalski
Czesław Puchalski
ŁKŁukasz Kogut
Łukasz Kogut
Grzegorz ZagułaGrzegorz Zaguła
Grzegorz Zaguła
Background/Objectives: Adaptogens are plant-derived substances that enhance the body’s nonspecific resistance to physical, chemical, biological, and psychological stressors by normalizing physiological functions. This article discusses the molecular mechanisms of action of seven key plant adaptogens—Rhodiola rosea, Schisandra chinensis, Withania somnifera, Eleutherococcus senticosus, Panax ginseng, Ocimum tenuiflorum, and Bacopa monnieri—in the context of chronic stress and lifestyle-related diseases. Methods: A review of the scientific literature is performed, including preclinical in vitro and in vivo studies, randomized placebo-controlled clinical trials, and studies employing network pharmacology analyses, molecular docking, and genomic techniques such as gene expression profiling. The interactions of active constituents with signaling pathways, molecular targets, and synergistic mechanisms were analyzed based on publications from the years 2010–2025. Results: Adaptogens exhibit pleiotropic activity: they regulate the HPA axis (Hypothalamic–Pituitary–Adrenal axis); induce Hsp70/Hsp16 expression; modulate SAPK/JNK, FOXO, and NF-κB pathways; and demonstrate antioxidant and mitoprotective effects. Specific mechanisms include: salidroside from R. rosea activating PI3K/Akt; schizandrin B from S. chinensis stimulating Hsp70; withanolides from W. somnifera inhibiting PDE4D; ginsenosides from P. ginseng suppressing FKBP51; and bacosides from B. monnieri enhancing acetylcholine synthesis. Clinical studies confirm reductions in cortisol levels (14–30%), decreased fatigue, and improved cognitive function without adverse effects. Conclusions: Understanding the molecular mechanisms of adaptogens supports their application in integrative medicine for the treatment of stress-related disorders, depression, anxiety, and neurodegenerative diseases. Further clinical studies are needed to optimize dosages and standardize extracts.

4 July 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
SSSebastian Such
Sebastian Such
Grzegorz ZagułaGrzegorz Zaguła
Grzegorz Zaguła
CPCzesław Puchalski
Czesław Puchalski
Maria CzernickaMaria Czernicka
Maria Czernicka
Background: German chamomile (Matricaria chamomilla L.) and Roman chamomile (Chamaemelum nobile (L.) All.) are widely consumed botanical materials increasingly used in nutraceuticals and functional foods. Although both are marketed as “chamomile”, they differ in phytochemical composition, sensory profile, and potential health-promoting properties. This review compares both species as dietary and functional ingredients. Methods: This narrative review summarises current evidence on the botanical characteristics, phytochemical profiles, dietary forms, biological activities, safety aspects, and functional food applications of M. chamomilla and C. nobile, with emphasis on species-specific differences relevant to nutritional use and formulation. Results: German chamomile is more extensively characterised and is particularly rich in apigenin-related flavonoids, luteolin derivatives, α-bisabolol, and matricin-derived chamazulene, which are associated with antioxidant, anti-inflammatory, calming, gastrointestinal, and metabolic effects. Roman chamomile is distinguished by an ester-rich essential oil profile and sesquiterpene lactones, including nobilin derivatives, which contribute to its characteristic aroma and complementary biological potential. Chamomile preparations differ substantially depending on species, extraction method, processing conditions, and food matrix, indicating that infusions, extracts, powders, and essential oils are not nutritionally equivalent. Conclusions: German and Roman chamomile should not be treated as interchangeable botanical ingredients. Their species-specific phytochemical profiles, sensory properties, and formulation behaviour should guide their application in nutraceuticals and functional foods. Future studies should focus on bioavailability, matrix interactions, clinical validation, and improved standardisation of chamomile-derived preparations.

Verified
Journal Article
Open access
PDF file
SSSebastian Such
Sebastian Such
Maria CzernickaMaria Czernicka
Maria Czernicka
Adaptogens are natural substances proposed to enhance non-specific resistance to stress and support physiological homeostasis. This review critically evaluates the phytochemistry, molecular mechanisms, human-health relevance, and translational evidence for seven proposed next-generation adaptogens: Lepidium meyenii, Astragalus membranaceus, Cordyceps militaris, Rhaponticum carthamoides, Gynostemma pentaphyllum, Centella asiatica, and Glycyrrhiza glabra. Evidence from mechanistic studies, clinical trials, systematic reviews, and meta-analyses was critically synthesised with emphasis on chemically characterised preparations, molecular target engagement, human exposure, and the distinction between preclinical and clinical evidence. The most consistently supported mechanisms include fatty acid amide hydrolase (FAAH) inhibition by maca macamides; telomerase- and senescence-related effects of Astragalus constituents; and AMP-activated protein kinase (AMPK)-centred metabolic regulation by cordycepin and gypenosides. Other relevant pathways include oestrogen receptor beta (ERβ)-related and phosphoinositide 3-kinase/protein kinase B (PI3K/Akt)-dependent anabolic signalling by phytoecdysteroids; brain-derived neurotrophic factor/tropomyosin receptor kinase B (BDNF/TrkB)-associated neuroplasticity and nuclear factor erythroid 2-related factor 2 (NRF2)-dependent redox regulation by C. asiatica; and 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) inhibition by glycyrrhetinic acid. However, evidence strength differs markedly among species and outcomes, and many mechanisms remain predominantly preclinical. Clinical translation is further limited by extract variability, incomplete pharmacokinetic characterisation, uncertain bioavailability, and safety concerns. The next-generation adaptogen concept should therefore be regarded as a pathway-oriented framework whose validation requires standardised preparations, mechanism-aligned biomarkers, clinically relevant endpoints, and rigorous safety assessment.

1 January 2025 in Farmacja Polska
Verified
Journal Article
Open access
PRPaweł Radkowski
Paweł Radkowski
SSSebastian Such
Sebastian Such
MŻMichał Żuraw
Michał Żuraw
JKJoanna Kostrzewa
Joanna Kostrzewa
ŁGŁukasz Grabarczyk
Łukasz Grabarczyk
Przedmiot badań. Celem niniejszego przeglądu było kompleksowe określenie i ocena interakcji pomiędzy preparatami ziołowymi a lekami stosowanymi w praktyce anestezjologicznej, ze szczególnym uwzględnieniem opioidów, np. fentanylu, leków nasennych (propofol, tiopental, midazolam, ketamina) oraz leków zwiotczających mięśnie szkieletowe. Cel badań. Podjęta w pracy tematyka jest niezwykle istotna, ponieważ interakcje ziołowo-lekowe w anestezjologii mogą wpływać na wydłużenie sedacji, przedłużać blok nerwowo-mięśniowy, czy też wywoływać krwawienia. Przewidywanie tych skutków jest utrudnione przez brak ujawniania stosowanych ziół przez pacjentów. Konsekwencje łączenia analizowanych tu substancji roślinnych z lekami stosowanymi w anestezjologii zależą od dawki oraz częstotliwości przyjmowania suplementu ziołowego, a także od czasu, jaki upłynął między jego ostatnim zastosowaniem a podaniem anestetyku. Materiały i metody. Analizie poddano mechanizmy farmakokinetyczne i farmakodynamiczne, obejmujące modulację enzymów cytochromu P450, enzymów II fazy - UGT, transporterów błonowych oraz receptora GABA_A, jak również wpływ na hemostazę. Wyniki. Wykazano, że zarówno korzeń z żeń-szenia, kłącze kurkumy, liście zielonej herbaty jak i wiele innych preparatów roślinnych opisywanych w tej pracy może zaburzać hemostazę, zwiększając ryzyko krwawień w okresie okołooperacyjnym, szczególnie przy jednoczesnym stosowaniu leków przeciwzakrzepowych. Nie stwierdzono jednak istotnych interakcji z propofolem. Wiązane jest to z jego metabolizmem omijającym główne izoformy CYP450. Niezależenie od tego opisano potencjalne synergizmy z kannabidiolem, a także z linalolem. Dla ketaminy, tiopentalu, ale też leków zwiotczających mięśnie wykazano możliwe modulacje działania na skutek podania preparatów ziołowych wpływających na kluczowe białka odpowiedzialne za metabolizm leków czy związków endogennych, co może skutkować zmianą czasu trwania efektu anestezji. Wymieniono także liczne, klinicznie istotne interakcje, przykładowo związki czynne ziela dziurawca zwyczajnego są zdolne do indukcji CYP3A4, co może prowadzić do obniżenia biodostępności midazolamu. Wykazano, że pewne preparaty ziołowe modulujące receptory GABA_A mogą nasilać sedację - w tekście wymieniono w tym kontekście m.in. preparaty pozyskiwane z kłączy i korzenia kozłka lekarskiego, ziele męczennicy, liście melisy oraz szyszki chmielu. Wnioski. Podsumowując, kompleksowy wywiad dotyczący stosowania preparatów ziołowych przez pacjentów powinien stanowić integralny element przygotowania do operacji. Zdecydowanie zaleca się zaprzestanie stosowania tych produktów na odpowiedni okres przed operacją, aby zminimalizować ryzyko niepożądanych interakcji między ziołami a lekami w praktyce anestezjologicznej.

16 October 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
Maria CzernickaMaria Czernicka
Maria Czernicka
SSSebastian Such
Sebastian Such
Natural products are important sources of redox-active phytochemicals, but meaningful interpretation of their biological effects requires accurate botanical and chemical characterization. The vernacular label “lotus” is applied to botanically distinct taxa belonging to the genera Nymphaea (Nymphaeaceae) and Nelumbo (Nelumbonaceae), despite their substantial taxonomic and phytochemical divergence. This review critically evaluates authenticated evidence on botanical identity, phenolic and alkaloid composition, antioxidant activity, redox-modulating mechanisms, translational relevance, and safety across selected species of both genera. Particular emphasis is placed on organ-specific phytochemical specialization, the contrasting distribution of flavonoids and benzylisoquinoline alkaloids, and the limitations of comparing antioxidant activity across heterogeneous extraction and assay systems. Available mechanistic studies implicate interconnected antioxidant-response, inflammatory, metabolic, autophagy, and glucose-handling pathways, but the evidence remains predominantly preclinical. Nelumbo nucifera is substantially better characterized than Nymphaea species, especially with respect to alkaloid chemistry, pharmacology, and toxicology, whereas evidence for Nymphaea remains more fragmented and species dependent. Botanical authentication, chemical standardization, pharmacokinetic characterization, and preparation-specific safety assessment are therefore essential for meaningful translation. Overall, the therapeutic potential of Nymphaea and Nelumbo is scientifically plausible, but current evidence is insufficient for broad clinical generalization or interchangeable use of materials marketed as “lotus”.

15 November 2026 in Molecules
Verified
Journal Article
Open access
PDF file
SSSebastian Such
Sebastian Such
Maciej BalawejderMaciej Balawejder
Maciej Balawejder
Racetams are structurally related but pharmacologically heterogeneous compounds studied in relation to cognition. This narrative and critical review compares piracetam, aniracetam, oxiracetam, pramiracetam, phenylpiracetam, fasoracetam, and levetiracetam with respect to chemical structure, stereochemistry, proposed mechanisms, clinical evidence, safety, and regulatory status. Literature searches identified historical publications, preclinical studies, clinical trials, systematic reviews, and meta-analyses relevant to these compounds. The findings indicate that a shared structural scaffold does not imply a common molecular target or equivalent clinical effects. Proposed mechanisms range from membrane-related effects and glutamatergic or cholinergic signaling to dopamine-transporter activity, metabotropic glutamate receptor-associated signaling, and SV2A binding by levetiracetam. Clinical evidence varies by compound, population, and outcome; many cognitive-enhancement claims rely on small or older trials, while several mechanistic observations derive from preclinical models. Animal findings cannot establish clinical neuroprotection, neurogenesis, or cognitive enhancement in humans. Levetiracetam has an established antiseizure indication, which does not establish a nootropic indication. Current evidence does not support class-wide conclusions about efficacy or long-term safety. Generative AI was used to assist with literature discovery and the preparation of schematic figures. All AI-suggested references were independently checked against PubMed records and DOI metadata, and the authors reviewed the AI-assisted material and take full responsibility for the accuracy and integrity of the manuscript. Further well-designed clinical trials and direct pharmacological comparisons are needed.